prednisolone hemisuccinate

Poland

Drugs containing this active substance

  • PREDASOL

    The medicine is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of organ transplant rejection, acute skin diseases, acute blood diseases, post-infarction syndrome, severe infectious diseases, adrenal cortex insufficiency, and pseudocroup.

    Form: solution for injection / infusion, powder and solvent for preparation of

    Active substance Dosage
    prednisolone hemisuccinate 50 mg

    ATC: H02AB06

    Manufacturer: mibe GmbH Pharmaceuticals

  • The medicinal product is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of organ transplant rejection, acute skin and blood diseases, post-infarction syndrome, severe infectious diseases, adrenal insufficiency, and pseudocroup.

    Form: solution for injection / infusion, powder and solvent for preparation of

    Active substance Dosage
    prednisolone hemisuccinate 25 mg

    ATC: H02AB06

    Manufacturer: mibe GmbH Pharmaceuticals

  • The medicine is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of organ transplant rejection, severe skin diseases, acute blood diseases, post-infarction syndrome, severe infectious diseases, adrenal cortex insufficiency, and pseudocroup.

    Form: solution for injection / infusion, powder and solvent for preparation of

    Active substance Dosage
    prednisolone hemisuccinate 250 mg

    ATC: H02AB06

    Manufacturer: mibe GmbH Pharmaceuticals

  • The medicine is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of kidney transplant rejection, severe skin diseases, acute blood disorders, post-infarction syndrome, certain severe infectious diseases, adrenal cortex insufficiency, and pseudocroup.

    Form: solution for injection / infusion, powder and solvent for preparation of

    Active substance Dosage
    prednisolone hemisuccinate 1000 mg

    ATC: H02AB06

    Manufacturer: mibe GmbH Pharmaceuticals